About US
Contact us
-
Almac Further Enhances 3rd Party Logistics Commercial Support Services for Niche/Orphan DrugsAlmac, a leading provider of contract services to the global pharmaceutical and biotech industries, announces the release of an enhanced 3rd Party Logistics (3PL) Customer Billing Application. In r2013/11/19
-
Pharma in India scrambles to appease wholesalers, chemistsNobody making or selling drugs inIndiawas happy when the government this year expanded price caps to nearly 350 drugs, but there seemed little for anyone to do. When wholesalers and retailers began ho2013/11/18
-
Medix Biochemica Announces European Launch of Antibody Production ServicesMedix Biochemica, producer of monoclonal antibodies for the global IVD industry and diagnostic rapid tests, is presenting its MedixMAB by Design and MedixMAB Manufacturing antibody production services2013/11/18
-
Merck KGaA hikes forecast, eyes deals as cost cuts keep deliveringOnce again,Merck KGaAreported a quicker-than-expected payoff from its big cost-cutting program. The German drugmaker hiked its profit forecast for the year, saying the changes it has made are deliveri2013/11/15
-
2013 FDA Approval Rates Suggest Record Year for Post-Launch SuccessA focus on hard to treat or specialist diseases is set to result in record post-launch sales for new drugs in 2013, according to newly-released report, “FDA Approval Rates: Niche Products Driving Reco2013/11/15
-
European Medicines Agency Updates on Development of its Policy on Publication and Access to Clinical Trial DataTheEuropean Medicines Agencyis currently reviewing and analysing more than 1000 comments received during the public consultation on its draft policy on publication and access to clinical trial data, w2013/11/14
-
FDA Approves Aptiom to Treat Seizures in AdultsFDA has approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy. Epilepsy is a brain disorder caused by abnormal or excessive activity in the brai2013/11/14
-
Breakthrough hep C meds aren't yet for sale, but critics already taking aim at pricesThe next generation ofhepatitis Ctreatments has investors excited--not to mention doctors, patients and drug company executives. But if the past is any indicator, those newfangled drugs are likely to2013/11/13
-
Bridging the Gap Between Basic Research and Industrial ApplicationProfessor Dr Pierre Jacobs, KU Leuven (Belgium), has received the BASF-DECHEMA Alwin Mittasch Special Prize for his research into materials and their use as process catalysts. The award, which comes w2013/11/13
-
Capsugel's Vcaps Plus HPMC Capsules Enhance Performance for Recently Approved LevomilnacipranCapsugel'sVcaps Plus HPMC (hypromellose) capsules are increasingly the preferred capsule option among pharmaceutical companies looking for innovative dosage forms to enhance product performance and im2013/11/12